A Study to Evaluate the Safety and Pharmacokinetics of MEDI0382 in Overweight/Obese Subjects of Japanese or Chinese Descent
Status:
Completed
Trial end date:
2018-04-12
Target enrollment:
Participant gender:
Summary
This is a phase I, randomized, blinded study to evaluate the safety and pharmacokinetics of
MEDI0382 following single dose administration to overweight/obese subjects of Japanese or
Chinese descent